Loading...

Brefeldin A Solution (1,000X)

Pricing & Availability
Regulatory Status
RUO
Other Names
BFA
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420601 1 mL 52€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Brefeldin A (BFA) is a protein transport inhibitor commonly used to enhance intracellular cytokine staining signals by blocking transport processes during cell activation. Especially useful for the intracellular staining of cytokines, BFA leads to the accumulation of most cytokines at the Golgi Complex/Endoplasmic Reticulum (see Jung, et al., 1993). Optimal conditions for use are cell type and time-dependent. Typically, protein transport inhibitors are included during in vitro cell activation cultures for 4-24 hours prior to harvest (see references below for additional information). Brefeldin A Solution is supplied as a 1,000X solution, which should be diluted to 1X in cell culture medium.

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
Brefeldin A Solution is supplied as a 1000X in DMSO, which should be diluted to 1X in cell culture medium.
Concentration
5.0 mg/ml
Storage & Handling
Store the Brefeldin A Solution (1,000X) between 2°C and 8°C. Note: DMSO freezes at this temperature.
Application

ICFC - Quality tested
Recommended Usage

Dilute the 1000X solution to 1X in the tissue culture medium. It is recommended that cells are cultured with brefeldin A for ≤ 24 hours, as this can become toxic for cell viability.

Application Notes

Completely thaw the solution before use, DMSO freezes at 4°C.  We recommend aliquotting the reagent into smaller volumes to avoid repeated freeze-thawing.  

Application References
  1. O'Sullivan BJ, et al. 2006. J. Immunol. 176:7278.
  2. Fuse S, et al. 2007. J. Immunol. 178:5227.
  3. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  4. Redfern CH,et al.2006.J. Clin Oncol.19:3107. PubMed
  5. Smithey MJ, et al. 2008. J. Immunol. 180:3406. PubMed
  6. Elzey BD, et al. 2008. Blood 111:38684. PubMed
  7. Nguyen KD, et al. 2008. J. Immunol. 181:5386. PubMed
  8. Miner MD, et al. 2008. Microb Pathog. 45:273. PubMed
  9. Goodridge HS, et al. 2009. J. Immunol. 182:1146. PubMed
  10. Markey KA, et al. 2009. Blood 113:5644. PubMed
  11. Wilcox RA, et al. 2009. Blood PubMed
  12. Zenaro E, et al. 2009. J. Leukoc Bio. PubMed
  13. Rozkova D, et al. 2009. Clin Immunol. 131:1. PubMed
  14. Butcher JP, et al. 2010. Clin Cancer Res. 16:2065.
  15. Boisvert M, et al. 2010. J. Virol. 84:7782. PubMed
  16. Liu WC, et al. 2010. J. Virol. 84:12011.15. Tawara I, et al. 2011. Clin Cancer Res. 17:77. PubMed
  17. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  18. Schmidt NW, et al. 2011. J. Immunol. 186:3836. PubMed
  19. Langkjaer A, et al. 2012. Clin Immunol. 145:1. PubMed
  20. Molinero LL, et al. 2012. PNAS. 109:18529. PubMed
  21. Li HW, et al. 2012. J. Immunol. 189:5572. PubMed
  22. Wang JM, et al. 2013. J. Virol. 87:4372. PubMed
  23. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  24. Wang Jm, et al. 2013. J Virol. 87:11626. PubMed
  25. Lee TH, et al. 2013. J Biol Chem. 288:32873. PubMed
  26. Shi L, et al. 2014. J. Immunol. 192:649. PubMed
  27. Bulati M, et al. 2014. Exp Gerontol. PubMed
  28. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  29. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  30. Miller ML, et al. 2014. PNAS. 111:7397. PubMed
  31. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  32. Zhou GL, et al. 2014. J Cell Sci. 127:3916. PubMed
  33. Rist MJ, et al. 2015. J Virol. 89:703. PubMed
Product Citations
  1. Wang R, et al. 2018. Oncoimmunology. 7:e1461303. PubMed
  2. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  3. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  4. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  5. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  6. Sun Y, et al. 2022. STAR Protoc. 3:101479. PubMed
  7. Redelman-Sidi G, et al. 2022. Cancer Immunol Res. 10:1241. PubMed
  8. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  9. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  10. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  11. Yang WL, et al. 2023. Nat Commun. 14:863. PubMed
  12. Wu Z, et al. 2023. EMBO Rep. 24:e56524. PubMed
  13. Li G, et al. 2023. Cell Death Dis. 14:185. PubMed
  14. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  15. Mohammadpour H, et al. 2023. Cell Rep. 42:112250. PubMed
  16. Jung HY, et al. 2023. Oncoimmunology. 12:2190671. PubMed
  17. Li Y, et al. 2023. Vaccines (Basel). 11:. PubMed
  18. Onyshchenko K, et al. 2023. Nat Commun. 14:2087. PubMed
  19. Zhou X, et al. 2023. Sci Rep. 13:6701. PubMed
  20. Ko ES, et al. 2023. Cell Commun Signal. 21:107. PubMed
  21. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  22. Thomas OG, et al. 2023. Sci Adv. 9:eadg3032. PubMed
  23. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  24. Adamo S, et al. 2023. Cell Host Microbe. 31:928. PubMed
  25. LaPorte KM, et al. 2023. J Immunother Cancer. 11:. PubMed
  26. Patskovsky Y, et al. 2023. Nat Commun. 14:3763. PubMed
  27. Yakkala C, et al. 2021. Front Immunol. 12:695150. PubMed
  28. Zheng B, et al. 2021. Int J Mol Sci. 22: . PubMed
  29. Alexander KL, et al. 2021. Gastroenterology. 161:522. PubMed
  30. Trinks N, et al. 2021. Commun Biol. 4:1151. PubMed
  31. Chen J, et al. 2022. Adv Healthc Mater. 11:e2101714. PubMed
  32. Persaud AT, et al. 2022. J Leukoc Biol. 111:573. PubMed
  33. Yu L, et al. 2022. FEBS J. 289:3241. PubMed
  34. Ritzel RM, et al. 2022. Geroscience. 44:1407. PubMed
  35. D'Angeli V, et al. 2022. Eur J Immunol. 52:1058. PubMed
  36. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  37. Kanbar JN, et al. 2022. J Exp Med. 219: . PubMed
  38. Minichino D, et al. 2022. J Leukoc Biol. 112:1089. PubMed
  39. Gao KM, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202327119. PubMed
  40. Liu H, et al. 2022. Cell Rep Med. 3:100660. PubMed
  41. Jondle CN, et al. 2022. J Virol. 96:e0063922. PubMed
  42. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  43. Hsieh T, et al. 2022. Front Immunol. 13:901030. PubMed
  44. Li FL, et al. 2022. EMBO J. 41:e110698. PubMed
  45. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  46. Dutt TS, et al. 2022. Cell Rep. 41:111783. PubMed
  47. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  48. Shamriz O, et al. 2023. Front Immunol. 13:1044933. PubMed
  49. Chan L, et al. 2022. Cells. 12: . PubMed
  50. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  51. Nanishi E, et al. 2023. NPJ Vaccines. 8:18. PubMed
  52. Hajjar S, et al. 2022. Cell Death Differ. 29:585. PubMed
  53. Li Y, et al. 2022. Brain Behav Immun. 101:1. PubMed
  54. Zander R, et al. 2022. Immunity. 55:475. PubMed
  55. Pymm P, et al. 2022. Cell Rep. 38:110449. PubMed
  56. Giles JR, et al. 2022. Immunity. 55:557. PubMed
  57. Ye L, et al. 2022. Cell Metab. 34:595. PubMed
  58. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  59. Zhao Y, et al. 2022. ACS Appl Mater Interfaces. 14:21872. PubMed
  60. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  61. Zhu S, et al. 2017. Exp Cell Res.. 10.1016/j.yexcr.2017.10.013. PubMed
  62. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  63. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  64. Pablo-Bernal R, et al. 2016. J Gerontol A Biol Sci Med Sci. 71: 610 - 618. PubMed
  65. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  66. Xin G, et al. 2021. Cancer Immunol Res. 9:454. PubMed
  67. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  68. Nesterenko PA, et al. 2021. Cell Rep. 37:110167. PubMed
  69. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  70. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  71. Fote GM, et al. 2022. J Cell Sci. 135:. PubMed
  72. Aguilar-Pineda JA, et al. 2021. iScience. 24:102993. PubMed
  73. Moudra A, et al. 2021. J Immunol. 206:2109. PubMed
  74. Maschmeyer P, et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.11.005. PubMed
  75. Yamamoto A, et al. 2019. J Clin Invest. 129:3640. PubMed
  76. Shi L, et al. 2014. J Immunol. 192:649. PubMed
  77. Weng RR, et al. 2021. Nat Commun. 12:2163. PubMed
  78. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  79. Piper CJM, et al. 2020. Cell Reports. 29(7):1878-1892.e7.. PubMed
  80. Gay MD, et al. 2020. Cancer Prev Res (Phila). . PubMed
  81. Just S, et al. 2016. Sci Rep. 6:39796. PubMed
  82. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  83. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  84. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  85. Krone A, et al. 2022. Sci Rep. 218:. PubMed
  86. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  87. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  88. Nguyen K, et al. 2008. J Immunol. 181:5386. PubMed
  89. Wilcox R, et al. 2009. Blood. 114:2936. PubMed
  90. Starnbach X 2015. J Immunol. 195: 1665-1675. PubMed
  91. Garg B, et al. 2016. Mutagenesis. 10.1093/mutage/gew023. PubMed
  92. Ruhland M, et al. 2016. Nat Commun. 7:11762. PubMed
  93. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  94. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  95. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  96. Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed
  97. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  98. Smithey M, et al. 2008. J Immunol. 180:3406. PubMed
  99. Rana A, et al. 2020. Front Immunol. 11:536. PubMed
  100. Dayoub O, et al. 2017. Sci Rep. 10.1038/s41598-017-09933-4. PubMed
  101. Martens A, et al. 2020. Nat Immunol. 21:381. PubMed
  102. Wang Z, et al. 2020. Autophagy. 1:. PubMed
  103. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  104. Hradilova N, et al. 2017. PLoS One. 12(2):e0171539. PubMed
  105. Griffiths K, et al. 2016. Nat Commun. 7:13894. PubMed
  106. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  107. Al-Attar A, et al. 2016. Data Brief. 8: 536-44. PubMed
  108. Gonzalez-Perez G, et al. 2016. J Immunol. 196: 3768 - 3779. PubMed
  109. Pablo-Bernal R, et al. 2015. J Infect Dis. 10.1093/infdis/jiv520. PubMed
  110. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  111. Kang X, et al. 2022. Vaccines (Basel). 10:. PubMed
  112. Jeong J, et al. 2021. Immune Netw. 21:e31. PubMed
  113. Jondle CN, et al. 2021. MBio. 12:. PubMed
  114. Yu H, et al. 2011. J Leukoc Biol. 90:205. PubMed
  115. Doll K, et al. 2016. J Immunol. 196: 4253 - 4262. PubMed
  116. Liu W, et al. 2016. J Virol. 90: 6085 - 6096. PubMed
  117. Fucikova J, et al. 2016. Blood. 128(26):3113-3124. PubMed
  118. Douthwaite J, et al. 2017. J Immunol. 198(1):528-537. PubMed
  119. Snyder LM, et al. 2022. Immunohorizons. 6:660. PubMed
  120. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  121. Liu W, et al. 2010. J Virol. 84:12011. PubMed
  122. Elzey B, et al. 2008. Blood. 111:3684. PubMed
  123. Ries M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006506. PubMed
  124. Rialdi A, et al. 2016. Science. 352: aad7993. PubMed
  125. Li H, et al. 2012. J Immunol. 189:5572. PubMed
  126. Carissimo G, et al. 2019. Life Sci Alliance. 2:e201900298. PubMed
  127. Wang Y, et al. 2020. Sci Adv. 6:eaba5412. PubMed
  128. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  129. Codo AC, et al. 2020. Cell Metab. 32:437. PubMed
  130. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  131. Shenoy AT, et al. 2021. Nat Commun. 12:5834. PubMed
  132. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
  133. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  134. Dumaine JE, et al. 2021. Elife. 10:. PubMed
  135. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  136. Jondle CN, et al. 2021. J Virol. 95:e0072621. PubMed
  137. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  138. Uddin MN, et al. 2022. Brain Behav Immun Health. 26:100563. PubMed
  139. Tawara I, et al. 2011. Clin Cancer Res. 0.761805556. PubMed
  140. Orlov M, et al. 2017. PLoS One.. 10.1371/journal.pone.018296. PubMed
  141. Martins M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006529. PubMed
  142. Gross C, et al. 2016. Neurol Neuroimmunol Neuroinflamm. 3: e289. PubMed
  143. Krämer B, et al. 2016. PLoS One. 11: 0162068. PubMed
  144. Crooks SD, et al. 2022. Immunohorizons. 6:705. PubMed
  145. Fang E, et al. 2022. MedComm (2020). 3:e117. PubMed
  146. Cao Y, et al. 2018. Nat Commun. 2.940972222. PubMed
  147. Emmer BT, et al. 2018. Elife. 7:e38839. PubMed
  148. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  149. Harty N 2011. J Immunol. 186:3836. PubMed
  150. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  151. Lee T, et al. 2013. J Biol Chem. 288:32873. PubMed
  152. Vigano S, et al. 2015. J Virol. 89: 7829-7840. PubMed
  153. Vacaflores A, et al. 2016. PLoS One. 11: 0157175. PubMed
  154. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  155. Kim J, et al. 2016. Nat Immunol. 17:1159-1166. PubMed
  156. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  157. Buqué A, et al. 2020. Nat Commun. 3.110416667. PubMed
  158. Redfern C, et al. 2006. J Clin Oncol. 24:3107. PubMed
  159. Yan H, et al. 2020. ACS Appl Mater Interfaces. 12:19324. PubMed
  160. Matisz C, et al. 2017. Sci Rep. 7:40631. PubMed
  161. Castro I, et al. 2016. J Virol. 90: 5280 - 5291. PubMed
  162. Zhang W, et al. 2015. Infect Immun . 83: 3213-3223. PubMed
  163. Ji L, et al. 2012. PLoS One. 7:e50909. PubMed
  164. Huang RS, et al. 2021. Curr Protoc. 1:e246. PubMed
  165. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  166. Gao Y, et al. 2022. Immunity. 55:1732. PubMed
  167. Han K, et al. 2021. Nat Metab. 3:318. PubMed
  168. Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed
  169. Bachy S, et al. 2022. iScience. 25:103758. PubMed
  170. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  171. Ngwenyama N, et al. 2019. JCI Insight. 4:e125527. PubMed
  172. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  173. Butchar J, et al. 2010. Clin Cancer Res. 2.100694444. PubMed
  174. Wang J, et al. 2013. J Virol. 87:4372. PubMed
  175. Nice T, et al. 2016. PLoS One. 12: 1005684. PubMed
  176. Pfeifle R, et al. 2016. Nat Immunol. 18:104-113. PubMed
  177. Krishnan A, et al. 2020. Am J Pathol. 190:1284. PubMed
  178. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  179. Grace PS, et al. 2021. Front Immunol. 12:679973. PubMed
  180. Li Y, et al. 2021. Vaccines (Basel). 9:. PubMed
  181. Liu W, et al. 2022. Bio Protoc. 12:e4285. PubMed
  182. Ma K, et al. 2022. iScience. 25:104347. PubMed
  183. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  184. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  185. Sekine T, et al. 2020. Cell. 183:158. PubMed
  186. Gogokhia L, et al. 2019. Cell Host Microbe. 25:285. PubMed
  187. Guo C, et al. 2018. Immunity. 49:842. PubMed
  188. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  189. Rossato C, et al. 2017. Biologicals. 10.1016/j.biologicals.2017.06.007. PubMed
  190. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  191. Loeuillard E, et al. 2020. J Clin Invest. 130:5380. PubMed
  192. Matsushita T, et al. 2015. Rheumatology. 101093/rumatology/kv331. PubMed
  193. Molinero L, et al. 2012. Proc Natl Acad Sci U S A. 109:18529. PubMed
  194. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  195. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  196. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  197. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  198. Stepanova E, et al. 2021. Microorganisms. 9:. PubMed
  199. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  200. Rosser EC, et al. 2020. Cell Metabolism. 31(4):837-851. PubMed
  201. Zenaro E, et al. 2009. J Leukoc Biol. 86:1393. PubMed
  202. Goodridge H, et al. 2009. J Immunol. 182:1146. PubMed
  203. Gnerlich J, et al. 2010. J Immunol. 185:4063. PubMed
  204. Boisvert M, et al. 2010. J Virol. 84:7782. PubMed
  205. Langkjær A, et al. 2012. Clin Immunol. 145:1. PubMed
  206. Rozková D, et al. 2009. Clin Immunol. 131:1. PubMed
  207. Miner M, et al. 2008. Microb Pathog. 45:273. PubMed
  208. Miller M, et al. 2014. Proc Natl Acad Sci U S A. 111:7397. PubMed
  209. Gartlan K, et al. 2015. Blood. 126: 1609-1620. PubMed
  210. Ulland T, et al. 2016. Nat Commun. 7:13180. PubMed
  211. Melacarne A, et al. 2021. Cell Reports. 36(1):109312. PubMed
  212. Tse SW, et al. 2021. Mol Ther. 29:2227. PubMed
  213. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  214. Markey K, et al. 2009. Blood. 113:5644. PubMed
  215. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  216. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  217. Theisen U, et al. 2020. J Cell Biol. :219. PubMed
  218. Dáňová K, et al. 2017. J Immunol. 198(2):729-740. PubMed
  219. Beyaz S, et al. 2016. Nat Immunol. 18:184-195. PubMed
  220. Kadivar M, et al. 2016. J Immunol. 197(12):4584-4592. PubMed
  221. Wang J, et al. 2013. J Virol. 87:11262. PubMed
  222. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  223. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  224. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  225. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  226. Li Z, et al. 2021. JCI Insight. 6:. PubMed
  227. Virtakoivu R, et al. 2021. Clin Cancer Res. 27:4205. PubMed
  228. Koschel J, et al. 2021. Cell Death Differ. 28:2257. PubMed
  229. FitzPatrick MEB, et al. 2021. Cell Rep. 34:108661. PubMed
  230. Bass VL, et al. 2021. Mol Syst Biol. 17:e10127. PubMed
  231. Landi A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.072. PubMed
  232. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  233. Bulati M, et al. 2014. Exp Gerontol. 54:123. PubMed
  234. Zhou G, et al. 2014. J Cell Sci. 127:3916. PubMed
  235. Rist M, et al. 2015. J Virol. 89:703. PubMed
  236. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  237. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  238. Mohammadpour H, et al. 2020. JCI Insight. 5:00. PubMed
  239. Gussarow D, et al. 2021. Front Med (Lausanne). 8:770381. PubMed
  240. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  241. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  242. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  243. Mackroth M, et al. 2016. PLoS Pathog. 12:e1005909. PubMed
  244. Rau M, et al. 2016. J Immunol. 196: 97 - 105. PubMed
  245. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  246. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  247. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  248. Genardi S, et al. 2020. Front Immunol. 11:610010. PubMed
  249. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  250. Ruland C, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.06.010. PubMed
  251. Ahmadi H,et al. 2017. Inflammopharmacology. . 10.1007/s10787-017-0410-8. PubMed
  252. Li J, et al. 2018. Redox Biol. 0.976388889. PubMed
  253. Krishna B, et al. 2016. Sci Rep. 6: 24674. PubMed
  254. Schridde A, et al. 2017. Mucosal Immunol. 10.1038/mi.2016.142. PubMed
  255. Wang W, et al. 2020. STAR Protoc. 1:100218. PubMed
  256. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  257. Lu G, et al. 2017. PLoS One. 12:e0178352. PubMed
  258. Orozco SL, et al. 2019. Cell Rep. 28:2275. PubMed
  259. Laczkó D, et al. 2020. Immunity. 53:724. PubMed
  260. Abshire C, et al. 2016. PLoS Pathog. 12:e1006088. PubMed
  261. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  262. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  263. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  264. Carrion B, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed
  265. Petrova T, et al. 2021. FEBS J. 288:5909. PubMed
  266. Nesterenko PA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  267. Matei DE, et al. 2021. Med (N Y). 2:864. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.
5. Jung T, et al. 1993. J. Immunol. Meth. 159:197.

Gene ID
NA

Related FAQs

The Brefeldin A solution freezes at 4°C . Is the solution still OK?

We recommend to thaw in warm water after removing from the fridge.  The Brefeldin A is dissolved in DMSO, which freezes at 18°C, so this is normal.  No one has reported any problems with the freeze/thaw cycles and this is how we recommend it is stored.   If customers are concerned, they can aliquot the Brefeldin A to avoid the freeze thaw.

How do I choose monensin or Brefeldin A solution?

Generally, Brefeldin A is more toxic for longer term incubations, so for shorter stimulations (6 hrs or less) use Brefeldin A.  For longer stimulations use monensin.  We recommend optimization for each cell type and protocol.

Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account